Xtant醫控股 XTNT 深 滬
已收盤 05-15 16:00:00 美东时间
0.4559
-0.014
-3.00%
華盛通- 最 高0.47
- 今 開0.467
- 成交量 12.41万股
- 最 低 0.4524
- 昨 收 0.47
- 總市值 6.39万
- 52周最高 0.95
- 市盈率 靜 13.77
- 換手率 0.09%
- 52周最低 0.438
- 委 比 0.00%
- 總股本 0.00亿
- 歷史最高 471.60
- 量 比 0.56
- 振 幅 3.74%
- 歷史最低 0.331
- 每 手 1
- 風險率 0.08%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 潜在涨幅257.14%！瑞杰金融上调InflaRx目标价至9美元，评级升至"强烈买入"
今日重点评级关注：瑞杰金融：上调InflaRx评级至"强烈买入"，目标价从7美元升至9美元；巴克莱：维持Orchestra BioMed Hldgs"超配"评级，目标价从12美元升至13美元
05-14 14:32
Xtant Medical Boosts 2026 Outlook Amid Tough Quarter
Xtant Medical Holdings Inc (($XTNT)) has held its Q1 earnings call. Read on for...
05-14 08:28
BTIG Reiterates Buy on Xtant Medical Holdings, Maintains $1 Price Target
BTIG analyst Ryan Zimmerman reiterates Xtant Medical Holdings (AMEX:XTNT) with a Buy and maintains $1 price target.
05-14 02:12
Xtant Medical Hldgs Q1 2026 Earnings Call Transcript
Xtant Medical Hldgs (AMEX:XTNT) released first-quarter financial results and ho...
05-13 21:50
Earnings Scheduled For May 13, 2026
Companies Reporting Before The Bell • Similarweb (NYSE:SMWB) is estimated to re...
05-13 19:11
Xtant Medical Raises FY2026 Sales Guidance from $95.000M-$99.000M to $101.000M-$105.000M vs $96.725M Est
2026 Financial GuidanceThe Company is today increasing its full-year 2026 revenue guidance to a range of $101 million to $105 million, from $95 million to $99 million previously, to reflect the recently announced
05-13 19:02
Xtant Medical Hldgs Q1 EPS $(0.02), Inline, Sales $20.884M Beat $20.164M Estimate
Xtant Medical Hldgs (AMEX:XTNT) reported quarterly losses of $(0.02) per share which met the analyst consensus estimate. The company reported quarterly sales of $20.884 million which beat the analyst consensus estimate
05-13 19:01
Xtant Medical Expands Trivium™ Portfolio with the Commercial Launch of Trivium™ Shaped
BELGRADE, Mont., May 6, 2026 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a medical technology company focused on surgical solutions for spinal and other orthopedic co...
05-06 20:00
Xtant Medical Holdings Acquires Exclusive U.S. Distribution Rights To Dilon Technologies' HEMOBLAST Bellows
Xtant Medical Holdings, Inc. (NYSE American: XTNT), a medical technology company focused on surgical solutions for spinal and other orthopedic conditions, and Dilon Technologies, Inc., a medical device manufacturer,
04-13 21:08
美股大行评级 | 存储分歧大！花旗大砍17%将美光目标价从510降至425美元；Bernstein上调希捷科技目标价从500升至620美元
今日重点评级关注：Maxim Group：上调Theriva Biologics评级至"买入"，目标价1美元；HC Wainwright & Co.：维持Bicara Therapeutics"买入"评级，目标价从40美元升至42美元
04-01 16:34
